University of Minnesota. Driven to Discover.
Of $1.6 billion appropriated, $412 million has been targeted to 131 projects.
The isolate shows high-level resistance to azithromycin and resistance to ceftriaxone.
The findings represent an opportunity to reduce unnecessary use of the drugs.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.